Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13971381 | 1.00 | HPGD (0.58) | HPGDCYP3A4TSHRALPIPKM | |
| SCHEMBL417469 | 1.00 | HPGD (0.58) | HPGDCYP3A4TSHRALPIPKM | |
| SCHEMBL9293068 | 0.89 | ESR1 (0.48) | HPGDCYP3A4TSHRPTGS1SLC7A5 | |
| SCHEMBL12258522 | 0.88 | MME (0.54) | TSHRPTGS1LMNA | |
| SCHEMBL12258523 | 0.88 | MME (0.54) | TSHRPTGS1LMNA | |
| SCHEMBL12258520 | 0.88 | MME (0.54) | TSHRPTGS1LMNA | |
| SCHEMBL265135 | 0.84 | CYP1A2 (0.61) | HPGDCYP3A4TSHRALPIPKM | |
| SCHEMBL265577 | 0.84 | CYP1A2 (0.61) | HPGDCYP3A4TSHRALPIPKM | |
| SCHEMBL22066481 | 0.84 | HPGD (0.59) | HPGDCYP3A4TSHRALPIPKM | |
| SCHEMBL65930 | 0.84 | CYP1A2 (0.61) | HPGDCYP3A4TSHRALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116715976-B | Chiral carbon-containing pentamethine cyanine dye, and preparation method and application thereof | 大连理工大学 | 2024-08-06 | — | — | CN | claimed |
| CN-116715976-A | Chiral carbon-containing pentamethine cyanine dye, and preparation method and application thereof | 大连理工大学 | 2023-09-08 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| CN-101343220-A | Preparation method for 3-methyl-4-phenyl-2-butanone | XI AN RUILIAN MODERN ELECTRONI (CN) | 2009-01-14 | — | — | CN | claimed |
| CN-1049884-C | Synthesis process of methylbenzyl acetone trihalide | PUDONG PHARMACEUTICAL FACTORY (CN) | 2000-03-01 | — | — | CN | claimed |
| CN-1174187-A | Synthesis process of methylbenzyl acetone trihalide | PUDONG PHARMACEUTICAL FACTORY (CN) | 1998-02-25 | — | — | CN | claimed |
| US-20250241905-A1 | 3-BETA-HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF | THE CLEVELAND CLINIC FOUNDATION | 2025-07-31 | — | — | US | disclosed |
| EP-4543437-A1 | 3-?HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF | THE CLEVELAND CLINIC FOUNDATION (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| CN-116715976-B | Chiral carbon-containing pentamethine cyanine dye, and preparation method and application thereof | 大连理工大学 | 2024-08-06 | — | — | CN | disclosed |
| US-11987506-B2 | Salt recovery solution and processes of use thereof | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-05-21 | — | — | US | disclosed |
| WO-2023250480-A1 | 3-βHSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF | THE CLEVELAND CLINIC FOUNDATION (US) | 2023-12-28 | — | — | WO | disclosed |
| CN-1174187-A | Synthesis process of methylbenzyl acetone trihalide | PUDONG PHARMACEUTICAL FACTORY (CN) | 1998-02-25 | — | — | CN | disclosed |
| EP-0206442-B1 | PREPARATION OF INDENES | THE STANDARD OIL COMPANY (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4686291-A | REACTING A METHYL SEC-ALKYL KETONE WITH A HALIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1987-08-11 | — | — | US | disclosed |
| US-4677238-A | CYCLODEHYDRATION OF ALDEHYDES OR KETONES | THE STANDARD OIL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| EP-0206442-A1 | Preparation of indenes | THE STANDARD OIL COMPANY (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4568782-A | CATALYTIC CYCLODEHYDRATION OF 3-PHENYLPROPIONALDEHYDES OR 3/PHENYLPROPYLEKETONES | THE STANDARD OIL COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| US-4092350-A | ANTIINFLAMMATORY AGENTS, RHEUMATIC DISEASES | TOYAMA CHEMICAL COMPANY LIMITED (JA) | 1978-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250241905-A1 | 3-BETA-HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF | HSD3B1, HSD3B2, HSD17B11 | HPGD 28/4885CYP3A4 391/4885TSHR 4391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.